
zzso zzso followed by zzso zzso stem cell transplantation zzso is a treatment option for aggressive and zzso multiple sclerosis zzso zzso is a zzso zzso approved for zzso zzso zzso unresponsive to zzso zzso Nothing is known about the use of zzso in patients after zzso We describe five female zzso patients with incomplete response to zzso zzso was then administered with abolition of both zzso and clinical zzso No severe adverse events, in particular opportunistic infections such as Progressive zzso zzso zzso were zzso Our results suggest that the use of zzso in aggressive zzso after zzso could be effective and zzso The very long-term risk of adverse events due to sequential aggressive zzso has to be zzso 

